Compass Therapeutics slides on stock offering launch
Shares of Compass Therapeutics CMPX.O down 5.3% post-market to $3.00 after equity raise news
Boston, Massachusetts-based oncology-focused biopharma launches offering of stock and pre-funded warrants; deal size not disclosed
Co intends to use net proceeds to conduct initial preparations for commercial readiness, to fund R&D, clinical development of its product candidates, among other purposes
Jefferies, Piper Sandler and Guggenheim are joint active bookrunners for the offering
Co has ~138.3 mln shares outstanding for ~$440 mln market cap, per LSEG data
CMPX shares on Tues finished down 5.1% at $3.17
Stock gained ~24% on Mon after co reported Q2 results and provided data on its pipeline
Avg rating among 10 analysts is "strongbuy" and median PT is $10.50 - LSEG
Shares ended 2024 at $1.45
Related Articles
National Debt Bomb Ignited? Musk Warns U.S. Will Be 1000% Bankrupt Without AI
TradingKey - Tesla (TSLA) CEO Elon Musk recently issued another warning regarding the rapidly ballooning U.S. national debt. He stated clearly that without artificial intelligence and robotics, the United States will inevitably head toward fiscal bankruptcy.
Tesla Stock Outlook: Competing With Rivian, Robotaxi Potential, and 2026 Prospects
There is much conversation about the prospect of investing in Tesla (TSLA) as we move closer to 2026. The volatility of its share price in 2025 is leading many investors to consider if they should purchase shares of Tesla given the alternatives available in terms of electric vehicles (Rivian, etc.).
A Crash After a Surge: Why Silver Lost 40% in a Week?
TradingKey - Spot silver (XAGUSD) prices continue to decline. Silver plunged 20% on Thursday, breaking below $71 per ounce, with the sell-off intensifying on Friday as prices fell further below $64. Compared to the all-time high set on January 29, silver prices have retraced more than 40%, wiping out nearly all gains accumulated over the previous month.
Is Bitcoin’s Four-Year Cycle Dead in 2026?
Is the Bitcoin 4-year cycle dead? After 2025 broke historical records with a red post-halving year, institutional analysts explore if the Bitcoin price has decoupled from the halving countdown. Analyze the impact of spot ETFs, global liquidity, and the roadmap to the 2028 halving in this 2026 market
